Thymoma: With a report of 5 cases

Reid, H; Marcus, R

doi:10.1002/bjs.18003614307

Cited by 20 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thymic tumours (Reid and Marcus, 1949) are suspected when there are symptoms of myasthenia gravis. Here a skiagram would show a shadow which, in the antero-posterior view, occupies the mediastinum to one or other side of the heart shadow and on a lateral view occupies the superior mediastinum above the heart.…”

Section: Discussionmentioning

confidence: 99%

Superior Mediastinal Terato-Dermoids

Brewer¹,

Marcus²

1952

Postgraduate Medical Journal

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Superior Mediastinal Terato-Dermoids

Brewer¹,

Marcus²

1952

Postgraduate Medical Journal

View full text Add to dashboard Cite

Thymomas: Clinicopathologic features, therapy, and prognosis

Batata

Martini

Huvos

et al. 1974

Cancer

211

View full text Add to dashboard Cite

Fifty‐four patients with thymoma were seen at Memorial Hospital from 1928 to 1972. There were 18 benign and 36 malignant thymomas. Benign tumors were completely encapsulated. Malignant tumors were non‐encapsulated or incompletely encapsulated and invasive. All patients with benign thymoma were treated by resection alone. None had recurrent disease or died with tumor for periods ranging from 5 to 17 years after resection. Patients with malignant thymoma treated by resection alone had recurrent tumor within 5 years and subsequently died of their disease. All malignant thymoma patients who were alive free of disease for 5 or more years had radiation therapy and resection. Clinicopathologic features indicating a poor prognosis were: a non‐encapsulated tumor of a predominantly epithelial cell type, superior vena caval syndrome, malignant pleural effusion, supraclavicular lymph node involvement, dysphagia, hoarseness, myasthenia gravis, erythroid hypoplasia, and hypogammaglobulinemia.

show abstract

The surgico-pathological aspects of myasthenia gravis

Reid

1949

Journal of British Surgery

Self Cite

View full text Add to dashboard Cite

Although the figures for long-term survival are small, they show a definite improvement on those for alternative forms of radiotherapy. Some selection of patients is essential; we should appreciate our limitations and c o n h e treatment to cases in which there is reasonable prospect of producing regression of the tumour mass with relief of symptoms. For patients with advanced disease and infection, colostomy alone is much less trying for the patient and results may be achieved more quickly for the remainder of the patient's life. The question of radiotherapy here needs careful consideration, for colostomy may reduce available ports of entry and so make adequate radiotherapy difficult. To attempt the hopeless is worse than useless, and the only indication for radiotherapy in very advanced disease is to try and relieve pain due to invasion of, or pressure on, the pelvic nerves.3. Treatment should be considered whenever the surgeon and pathologist report that the disease has extended beyond the rectal wall. Untreated, 50 per cent of these patients will develop recurrences and metastases from which they will die. Radiotherapy is not advised as a routine pre-operative measure. Profound changes occur in the pelvic tissues following this heavy irradiation and the risks of necrosis are high. 4. We do not consider that the improvement in the effects of these radiations is due to the shorter wave-length of the million-volt X rays. It is not a difference in biological effect, but is due rather to the increased depth-dose and to the greater accuracy, efficiency, and ease of application.

show abstract

Thymoma: With a report of 5 cases

Cited by 20 publications

References 15 publications

Superior Mediastinal Terato-Dermoids

Superior Mediastinal Terato-Dermoids

Thymomas: Clinicopathologic features, therapy, and prognosis

The surgico-pathological aspects of myasthenia gravis

Contact Info

Product

Resources

About